Medical Oncology

Doç. Dr. Fatih Tay

Doctor and researcher Ali Osman Sönmez Onkoloji Hastanesi Bursa
Breast Neoplasms
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyMedical Oncologysaglik.gov.trFrom source
  • InstitutionAli Osman Sönmez Onkoloji Hastanesisaglik.gov.trFrom source
  • Area of workBreast NeoplasmsExtracted from 2 publications · Model version —From source
  • Publications14 publicationsORCID, OpenAlexFrom source
  • ORCID0000-0002-4672-4173ORCIDFrom source
  • Last synchronised5 November 2026 07:49https://bursaonkoloji.saglik.gov.tr/TR-855219/doktorlarimiz.html#fatih-taysaglik.gov.tr

Scientific work

Publications on Breast Neoplasms

14 publications

  1. Influence of bone metastases on presentation and management of malignant hypercalcemia: a single-center cohort

    Anatolian Current Medical Journal, 2026

    DOI 10.38053/acmj.1912366 Open-access full textSource: ORCID

  2. Neutropenia and G-CSF use in patients receiving FOLFOX during the COVID-19 pandemic

    Journal of Oncology Pharmacy Practice, 2026

    DOI 10.1177/10781552261434482 PMID 41885415 Source: ORCID

  3. Prognostic value of ALBI score in lung cancer patients with liver metastases and hepatic failure: a single-center experience

    Anatolian Current Medical Journal, 2025

    DOI 10.38053/acmj.1714895 Open-access full textSource: ORCID

  4. A propensity score‐matched comparison of neoadjuvant chemoradiotherapy with cisplatin‐ 5FU and carboplatin–paclitaxel in locally advanced esophageal squamous cell carcinoma: A Turkish oncology group study

    Cancer Medicine, 2024

    DOI 10.1002/cam4.70002 PMID 39030808 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  5. The impact of human epidermal growth factor receptor-2 (low) status on the efficacy of first line cyclin-dependent kinase 4/6 inhibitors in advanced breast cancer

    Medicine, 2024

    DOI 10.1097/md.0000000000038828 PMID 39058877 2 citations (OpenAlex) Open-access full textSource: OpenAlex

  6. Gastric cancer patient characteristics in a city in the Central Anatolian Region of Turkey: A single-center descriptive study

    Journal of Current Hematology & Oncology Research, 2023

    DOI 10.51271/jchor-0009 1 citation (OpenAlex) Open-access full textSource: ORCID

  7. Prognostic Markers after Hepatic Function Impairment in Patients with Pancreatic Adenocarcinoma

    Journal of the College of Physicians and Surgeons Pakistan, 2023

    DOI 10.29271/jcpsp.2023.01.32 PMID 36597232 1 citation (Europe PMC) Open-access full textSource: ORCID

  8. Novel inflammatory markers and prognostic importance of platinum-sensitive ovarian carcinoma relapse

    Srpski arhiv za celokupno lekarstvo, 2023

    DOI 10.2298/sarh221122057t 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  9. The Effects of Type 2 Diabetes Mellitus and Hypertension on Survival in Patients with Hepatic Dysfunction and Malignant Solid Tumors

    Eurasian Journal of Medical Investigation, 2023

    DOI 10.14744/ejmi.2023.67812 Open-access full textSource: OpenAlex

  10. Prognostic Importance of Combined Use of MELD Scores and SII in Hepatic Visceral Crisis in Patients with Solid Tumours

    Journal of College of Physicians And Surgeons Pakistan, 2023

    DOI 10.29271/jcpsp.2023.08.879 PMID 37553926 5 citations (OpenAlex) Open-access full textSource: OpenAlex

View all 14 publications